Stay updated with breaking news from T Cell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Researchers at the University of Houston are working to make T-cell immunotherapy safer, developing a tool called CrossDome, which uses a combination of genetic and biochemical information to predict if T-cell immunotherapies might mistakenly attack healthy cells.
CAR T-cell therapy showed efficacy in achieving complete responses among patients with relapsed or refractory CLL or SLL after BTKi and BCL2 inhibitor.
Researchers describe the Treg-cell-inducing activity of lipid extracts from the feces of specific-pathogen-free mice.
At the 2023 American Society for Clinical Oncology Annual Meeting—to be held June 2-6 in Chicago, Illinois—Fred Hutchinson Cancer Center experts will present research spanning survivorship, advances in treatments and clinical trials, how access to cancer care affects outcomes, integrative medicine and more.
Researchers described a novel strategy for controlling severe acute respiratory syndrome coronavirus 2.